Table 6.

Multiple logistic regression analysis

Variable selection	Factor		Adjusted ROR	95% CI	p	GVIF
Forced	Patient demographics	Male (ref: female)	1.35	1.25–1.46	3.07 × 10−15	1.15
		Over 60 years old (ref: under 60 years old)	2.32	2.12–2.54	2.55 × 10−75	1.10
		BPH	13.96	12.74–15.30	1.02 × 10−690	1.18
		Depression	1.36	1.13–1.63	1.11 × 10−3	1.86
Forward-backward stepwise selection	SGA	Risperidone	2.30	1.67–3.15	2.59 × 10−7	1.11
		Quetiapine	2.02	1.46–2.81	2.40 × 10−5	1.10
		Aripiprazole	1.56	1.09–2.22	0.015	1.09
		Blonanserin	2.19	1.29–3.73	3.65 × 10−3	1.09
		Brexpiprazole	2.64	1.31–5.31	6.52 × 10−3	1.03
		Lurasidone	6.31	3.59–11.10	1.98 × 10−10	1.06
	FGA	Chlorpromazine	2.01	1.29–3.13.	2.00 × 10−3	1.09
		Prochlorperazine	5.16	2.25–11.87	1.11 × 10−4	1.00
	BZ	Etizolam	2.13	1.47–3.09	6.55 × 10−5	1.14
		Clotiazepam	8.36	4.91–14.21	4.53 × 10−15	1.12
		Fludiazepam	81.56	22.33–297.89	2.75 × 10−11	1.07
	Antidepressant	Escitalopram	3.12	1.92–5.06	4.21 × 10−6	1.05
		Sertraline	2.84	1.82–4.42	4.03 × 10−6	1.09
		Paroxetine	1.71	1.17–2.49	5.47 × 10−3	1.12
		Fluvoxamine	1.77	1.05–3.00	0.033	1.10
		Duloxetine	3.01	2.15–4.21	1.16 × 10−10	1.05
		Venlafaxine	30.88	24.24–39.32	4.00 × 10−170	1.43
		Milnacipran	2.92	1.62–5.28	3.82 × 10−4	1.12
		Vortioxetine	3.64	1.67–7.92	1.16 × 10−3	1.03
		Mirtazapine	1.99	1.37–2.88	2.82 × 10−4	1.12
		Amitriptyline	3.93	2.26–6.84	1.22 × 10−6	1.06
		Imipramine	3.23	1.38–7.55	6.34 × 10−3	1.03
		Maprotiline	4.08	1.99–8.34	1.17 × 10−4	1.08

BPH, benign prostatic hyperplasia; BZs, benzodiazepines; FGA, first-generation antipsychotics; GVIF: generalized variance inflation factor, SGA, second-generation antipsychotics; ROR, reporting odds ratio; 95%CI, 95% confidence interval